Tele: 561.316.3330
Breaking Medical Device News

Thursday, October 21, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeEzraNew Full-Body Scan Detects Up To 11 Cancers In Men and 13...

New Full-Body Scan Detects Up To 11 Cancers In Men and 13 In Women

Ezra, the technology-driven healthcare company creating a new standard for early cancer detection launched its full-body MRI scanning program. Ezra provides its members with a direct-to-consumer service that enables them to get screened for cancer using an MRI scan that’s fast, accurate, and affordable. Ezra’s new full-body protocol can detect up to 11 cancers in men and 13 in women.

“We should all check our bodies for cancer as part of our routine health regimen. To make that possible, we’re aiming to combine a  better patient experience with the most advanced medical imaging technology and the latest developments in artificial intelligence,” said Emi Gal, CEO & co-founder of Ezra. “Our goal is to improve the speed, accuracy and affordability of cancer screening, and I’m thrilled to be announcing our full-body MRI-based cancer screening program.”

cancersIn an effort to make MRI-based cancer screening affordable to as many people as possible, Ezra offers multiple plans: The Ezra Full-Body Scan is available for $1,950, and single-region scans (such as pelvic or abdominal) are available for as little as $675. Members can also pay using a no-interest payment plan in 12 monthly installments.

The American Cancer Society estimates that there will be over 1.7 million new cases of cancer diagnosed in the United States this year alone — over 600,000 of which will be lethal.1 Almost 50% of cancer patients are detected late2, and only 2 out of 10 late-stage cancer patients survive longer than 5 years.3 Ezra’s mission is to help all these men and women detect cancer early, by creating fast, accurate, affordable and non-invasive cancer screening solutions.

In January 2019, Ezra launched its MRI-based prostate cancer screening program. The program’s goal is to leverage new technologies to catch prostate cancer as early as possible and help men avoid unnecessary prostate biopsies. Since the launch, almost 1,000 individuals have signed up, hundreds of men have been scanned, and Ezra has successfully helped members detect prostate cancer and avoid unnecessary prostate biopsies.

“We are developing innovative AI technologies that assist radiologists in detecting cancer earlier, faster, and more accurately than ever before. I cannot think of a better use of AI than to help people live longer and healthier lives,” says CTO and co-founder Diego Cantor, PhD.

In the four months since launch, Ezra has also assembled a stellar board of medical advisors, including Columbia’s Dr. Azra Raza, Dr. Siddhartha Mukherjee, and Dr. Joseph Alukal, Dr. Oguz Akin from Memorial Sloan Kettering Cancer Center, as well as RadNet’s Dr. Lawrence N. Tanenbaum, Dr. John Melnick and Dr. Charles Fiske. The company has also expanded to eight new imaging facilities across New York’s five boroughs and New Jersey. Ezra plans to expand to additional U.S. cities by the end of the year, providing early cancer detection to men and women across the country.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Contraline Closes $10.7 Million Series A Financing to Become a Clinical Stage Company

This infusion of capital will support the initiation of a first-in-human trial of ADAM™, the world’s first hydrogel implant designed to provide long-lasting, non-permanent contraception for men.

Adam S. Epstein New CEO of AliMed, Inc.

In his prior role as Chief Commercial Officer, Epstein directed all customer-facing, demand generation and product development activities. Under his new leadership, AliMed will continue to build a robust portfolio of contracted positions with major, national GPO’s, IDN’s, and Distribution partners to drive sales growth.

Tony Collins Appointed CFO of Xenter

“Xenter is building a platform for medical innovations that is transformational. The only way we can achieve our objectives is if we have great leaders like Tony Collins leading our company,” stated Richard J. Linder, Founder, Chairman & CEO of Xenter, Inc. “Tony brings incredible depth and experience to his new role as Chief Financial Officer.

Scott Sexton Appointed President at FIGUR8

"Scott brings to FIGUR8 30 years of workers' compensation, casualty, disability, and commercial health experience, most recently serving as a market leader for CorVel's national carrier practice sales team," said Nan-Wei Gong, CEO, and co-founder of FIGUR8.

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Luciana Borio MD is a respected physician with vast experience in advancing major regulatory and policy agendas for the United States.

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

By using this website you agree to accept Medical Device News Magazine Privacy Policy